SciencemRNA Cancer Vaccine Halts Melanoma in Phase 3 TrialModerna and Merck's personalized mRNA vaccine stopped melanoma returning post-surgery in a landmark Phase 3 trial of 1,000 high-risk patients.
TechnologyCambridge Lab Grows Human Organoids to Cut Animal TestingUK scientists are growing miniature human organs from NHS patients' cells to replace animal tests — backed by £20 million in Medical Research Council funding.
TechnologyNew Gene Test Could Spare Two-Thirds of Breast Cancer Patients from ChemoA 4,000-person international trial of the Prosigna genomic test found that most early breast cancer patients can safely skip chemotherapy with no loss in five-year survival.
